Collagen tripeptide, and why it is injected with hyaluronic acid

Two problems, two ingredients

An osteoarthritic knee has two things wrong with it at once. The joint fluid has lost its thickness and cushioning, and the cartilage matrix is being broken down faster than the cells can rebuild it.

Hyaluronic acid addresses the first. It restores viscosity, cushions load and damps inflammation, which is why it relieves pain.2 It does nothing directly for the second.

Collagen tripeptide addresses the second. It is a signalling molecule for the cells that maintain cartilage, and it is small enough to reach them.

Why the size of the peptide matters

Cartilage is dense. Large molecules stay in the joint cavity and never reach the chondrocytes embedded in the tissue. At 16 to 18 kDa, collagen tripeptide is small enough to diffuse into cartilage rather than washing around it.

Once there, it stimulates chondrocytes and fibroblasts to increase synthesis of cartilage matrix, and inhibits the degradation side of the same balance. The intention is not to add cartilage but to slow the rate at which it is being lost while the pain is being controlled.

Not the same as collagen you can buy

Oral collagen supplements are digested into amino acids and distributed throughout the body. Whatever reaches the knee arrives at an unknown dose, long after it was swallowed. An injection delivers a known quantity into the joint in one action. The two are not comparable, and a supplement is not a substitute for an injection any more than the reverse.

The injectable peptide is also synthetic and highly purified rather than extracted from bovine or porcine tissue, which removes both the immunogenicity concern and the dietary restriction that animal-derived material raises for many patients in Malaysia.

What the published study found

The clearest evidence for the combination comes from a 2024 study in Frontiers in Medicine, which followed 29 patients with 34 affected knees.1 These were not easy knees: all had knee osteoarthritis together with calcium pyrophosphate deposition, a combination known for more aggressive inflammation and faster cartilage loss than osteoarthritis alone. The median radiographic grade was 3, and a fifth of the group had already failed hyaluronic acid or PRP.

Each patient received a single ultrasound-guided injection and was followed at one, three and six months. Pain fell significantly at every follow-up point against baseline. Using the accepted thresholds for a clinically meaningful change, 79 per cent reached it on pain score and 83 per cent on the WOMAC function index. No injection-related side effects were recorded, and no patient had a post-injection flare.

Where this fits in your options

If your knee is acutely inflamed today, a corticosteroid will act faster. If you are young, active and in the early stages, PRP is worth discussing. If what you want is the longest useful interval from one visit, with a standardised dose and a predictable price, the hyaluronic acid and collagen tripeptide combination is the option built for that.